rethinkTHC Search
Menu
Study breakdown

CB1 receptor gene expression changes across brain development and is altered in schizophrenia, with COMT genotype modifying the trajectory

Cross SectionalStrong evidence
The takeaway

Postmortem analysis of human brain tissue found CB1 receptor (CNR1) expression is highest in fetal brain, drops after birth, and is decreased in schizophrenia, with the COMT Val158Met genotype modifying the developmental trajectory.

Psychiatric geneticists, developmental neuroscientists, and schizophrenia researchers studying gene-environment interactions.

CNR1 highest in fetal brain; COMT Val158 modifies developmental trajectory; decreased in schizophrenia

What the researchers found

CNR1 expression is high in fetal prefrontal cortex and hippocampus, then drops dramatically after birth. The lifespan trajectory of CNR1 in DLPFC was modified by COMT Val158Met genotype: valine carriers showed stronger age-related decline. CNR1 methylation at cg02498983 increased with age (inversely correlated with expression) and was strongest in valine carriers. CNR1 was decreased in schizophrenia DLPFC but upregulated in schizophrenia suicide victims. THC and ethanol were each associated with dysregulated CNR1 in affective disorder PFC. A novel CNR1 transcript was predicted by SNP rs806368.

Why it matters

Published in Translational Psychiatry, this maps the CB1 receptor across the human lifespan and shows that both genetic variation (COMT) and environmental exposure (THC) interact to determine CB1 expression. This gene-by-environment framework helps explain why adolescent cannabis use specifically increases psychosis risk.

The numbers in context

CNR1 highest in fetal brain; drops postnatally; COMT Val carriers: stronger decline and stronger methylation increase; CNR1 decreased in schizophrenia DLPFC; upregulated in schizophrenia suicide; THC and ethanol each dysregulate CNR1.

How the study worked

Postmortem human brain tissue analysis of CNR1 mRNA expression and DNA methylation across prefrontal cortex, hippocampus, and caudate from developmental samples and schizophrenia cases. eQTL analysis and COMT genotype interaction testing.

What this study cannot tell us

Postmortem tissue (cannot determine temporal sequences in living brain); relatively small samples per condition; medication effects not fully controlled; COMT genotype analysis limited to Caucasian subjects; cannot determine if CNR1 changes cause or result from schizophrenia.

How to read the evidence

Strong: published in Translational Psychiatry with comprehensive lifespan mapping, genetic interaction, and multi-region analysis.

When this study was published

Published 2020.

The bigger picture

The COMT genotype interaction explains individual vulnerability: some people (Val/Val carriers) may have CB1 receptors that are more sensitive to age-related decline and potentially more susceptible to cannabis-induced disruption during adolescence, when the developmental trajectory is most dynamic.

Questions still open

  • Should COMT genotyping inform cannabis risk counseling? Would restoring CNR1 expression in schizophrenia improve symptoms?

Common questions

Why are teenagers more vulnerable to cannabis effects on psychosis?
This study shows CB1 receptor (CNR1) expression is dynamically changing during development, dropping from high fetal levels after birth. The COMT Val158Met genotype modifies this trajectory. Cannabis use during this dynamic period may disrupt a critical developmental process.
Is there a genetic test for cannabis psychosis risk?
The COMT Val158Met genotype modified the CB1 receptor developmental trajectory, suggesting genetic factors influence vulnerability. However, this is early-stage research and genotyping cannot yet predict individual risk with clinical utility.

Read the original research

Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia.

Translational psychiatry, 10(1), 158

Citation

Tao, Ran; Li, Chao; Jaffe, Andrew E; Shin, Joo Heon; Deep-Soboslay, Amy; Yamin, Rae'e; Weinberger, Daniel R; Hyde, Thomas M; Kleinman, Joel E. (2020). Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia.. Translational psychiatry, 10(1), 158. https://doi.org/10.1038/s41398-020-0832-8

Explore the wider topic